Vilobelimab (Anti-Complement C5) | Read Reviews & Product Use Citations

Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

Purity & Quality Control

Batch: A310101 Purity: 99% Protein concentration: 5.5mg/ml Endotoxin Level: ＜1EU/mg

99

Biological Activity

Description	Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

References
[1] Bauer M, et al. Crit Care Explor. 2021 Nov 17;3(11):e0577.

References

[1] Bauer M, et al. Crit Care Explor. 2021 Nov 17;3(11):e0577.

Product Details

CAS No.	2250440-41-4
Isotype	Human IgG4SP
Source	CHO
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field